Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
But it also targets an additional hormone receptor (GIP)
Allergic reaction: Serious allergic reactions have been reported
G., Annett, M
Considering Eli Lilly's current revenue structure and the fact that tirzepatide is in a stage of rapid revenue growth, and the market has a positive growth expectation for it, the performance created by this drug is one of the core driving forces for the company's valuation switch, providing more room for the further rise of Eli Lilly's stock price
US$ 24.58
US$ 26.91
US$ 21.80
US$ 24.98
